Janus Henderson Investors
Investor profile
Deals
3
distinct rounds
Companies
3
backed
Active span
2018–2025
8 yrs
Total round €
€243M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- SV Health Investors2
- Andera Partners1
- Avidity Partners1
- British Patient Capital1
- EQT Life Sciences1
- Fidelity Management & Research Company LLC1
- Invus1
- IP Group PLC1
- Jeito Capital1
- M Ventures1
- Monashee Investment Management LLC1
- Novartis Venture Fund1
- Omega Funds1
- Pfizer Ventures1
- Piper Heartland Healthcare Capital1
- Point72 Ventures1
- RA Capital Management1
- Ridgeback Capital Investments1
- Schroders Capital1
- Sofinnova Partners1
- Syncona Partners1
- Tekla Capital Management1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Artios | UK | 1 | €99M |
| Aprea Therapeutics | Sweden | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Artios | Series D+ | €99M | 2025-11 |
| Aprea Therapeutics | Series C | €5.0M | 2018-12 |